0.558

- (-%)
Range - - -   (-%)
Open -
Previous Close 0.558
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume -
Value -
Remark
Delayed prices. Updated at 11 Jun 2022 04:00.
Data powered by
View All Events

About ZOSANO PHARMA CORP

Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a variety of indications. Its microneedle patch system has the potential to deliver numerous medications for a variety of indications in commercial markets. Its short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an existing drug and attached to an adhesive patch. Its lead product candidates, and the indications it treats include, Weekly ZP-PTH, for severe osteoporosis, ZP-Glucagon, for severe hypoglycemia, and ZP-Triptan, for migraine. In January 2014, it entered into a strategic partnership and license agreement with Novo Nordisk A/S (Novo Nordisk), to develop a microneedle patch product.

There are 5 followers

Followers
0
Followers
2
Followers
0
Followers
0
Followers
0